Author
Listed:
- Carl A B Pearson
- Fiammetta Bozzani
- Simon R Procter
- Nicholas G Davies
- Maryam Huda
- Henning Tarp Jensen
- Marcus Keogh-Brown
- Muhammad Khalid
- Sedona Sweeney
- Sergio Torres-Rueda
- CHiL COVID-19 Working Group
- CMMID COVID-19 Working Group
- Rosalind M Eggo
- Anna Vassall
- Mark Jit
Abstract
Background: Multiple Coronavirus Disease 2019 (COVID-19) vaccines appear to be safe and efficacious, but only high-income countries have the resources to procure sufficient vaccine doses for most of their eligible populations. The World Health Organization has published guidelines for vaccine prioritisation, but most vaccine impact projections have focused on high-income countries, and few incorporate economic considerations. To address this evidence gap, we projected the health and economic impact of different vaccination scenarios in Sindh Province, Pakistan (population: 48 million). Methods and findings: We fitted a compartmental transmission model to COVID-19 cases and deaths in Sindh from 30 April to 15 September 2020. We then projected cases, deaths, and hospitalisation outcomes over 10 years under different vaccine scenarios. Finally, we combined these projections with a detailed economic model to estimate incremental costs (from healthcare and partial societal perspectives), disability-adjusted life years (DALYs), and incremental cost-effectiveness ratio (ICER) for each scenario. Conclusions: COVID-19 vaccination can have a considerable health impact and is likely to be cost-effective if more optimistic vaccine scenarios apply. Preventing severe disease is an important contributor to this impact. However, the advantage of prioritising older, high-risk populations is smaller in generally younger populations. This reduction is especially true in populations with more past transmission, and if the vaccine is likely to further impede transmission rather than just disease. Those conditions are typical of many low- and middle-income countries. In a modelling study, Carl A B Pearson and coauthors investigate the health impact and cost-effectiveness of various COVID-19 vaccination scenarios in Sindh Province, PakistanWhy was this study done?: What did the researchers do and find?: What do these findings mean?:
Suggested Citation
Carl A B Pearson & Fiammetta Bozzani & Simon R Procter & Nicholas G Davies & Maryam Huda & Henning Tarp Jensen & Marcus Keogh-Brown & Muhammad Khalid & Sedona Sweeney & Sergio Torres-Rueda & CHiL COVI, 2021.
"COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness,"
PLOS Medicine, Public Library of Science, vol. 18(10), pages 1-19, October.
Handle:
RePEc:plo:pmed00:1003815
DOI: 10.1371/journal.pmed.1003815
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Francis J Ruiz & Sergio Torres-Rueda & Carl A B Pearson & Eleanor Bergren & Chinyere Okeke & Simon R Procter & Andres Madriz-Montero & Mark Jit & Anna Vassall & Benjamin S C Uzochukwu, 2023.
"What, how and who: Cost-effectiveness analyses of COVID-19 vaccination to inform key policies in Nigeria,"
PLOS Global Public Health, Public Library of Science, vol. 3(3), pages 1-19, March.
- Mario Cesare Nurchis & Alberto Lontano & Domenico Pascucci & Martina Sapienza & Eleonora Marziali & Francesco Castrini & Rosaria Messina & Luca Regazzi & Francesco Andrea Causio & Andrea Di Pilla & Gi, 2022.
"COVID-19 Vaccination Campaign among the Health Workers of Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Cost–Benefit Analysis,"
IJERPH, MDPI, vol. 19(13), pages 1-10, June.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pmed00:1003815. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosmedicine (email available below). General contact details of provider: https://journals.plos.org/plosmedicine/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.